ArticleScientific reports2024
Therapeutic and antioxidant properties of Acridocarpus monodii Arène & Jaeger, an endemic plant of Dogon Country in Mali.
Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Biological activity, UHPLC-MS phytochemical profiling, and computational studies of the leaf extract of Acridocarpus socotranus.Scientific reports · 2025Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Acridocarpus monodii Arène & Jaeger is an endemic plant species to the ''Dogon Country'' in Mali. This species is highly popular in Dogon ethnic groups, but no scientific data on its medicinal and biochemical properties are available in Mali. This work aimed to list its medicinal uses and assess its phytochemical composition and antioxidant power. An ethnobotanical investigation based on semi structured questionnaire was used to identify the traditional uses of A. monodii among the local population in three villages (Ireli, Youdiou and Yon-biré) inside ''Dogon country'' in Mali. The phytochemical composition was determined using qualitative tests, while the antioxidant potency was performed using 2,2-diphenyl-1-picryhydazyl (DPPH) and phosphomolybdate (TAC) tests. A total of 45 people were interviewed, the majority of whom were male (82.20%) and over 52 years of age. A. monodii is used to treat a dozen pathologies or diseases, dominated by malaria (71.10%), yellow fever (24.40%) and dysuria (20%). Although, all parts of this species are used to treat these pathologies, leaves (88.90%) were the most coveted followed by roots (37.80%). The use of these parts was significantly (p = 0.016 < 0.05) associated with the educational levels of the respondents (77.70%), who coveted primarily roots and barks, and thus constituted a threat to the species. These medicinal recipes derived from these organs were mostly prepared as decoctions, before being administered by oral (100%) or bath (82.20%) routes. Extracts of A. monodii were found to contain various biocompounds, especially a high quantity of flavonoids and polyphenols and demonstrated increased in vitro antioxidant inhibitory effects. The decoction extracts showed the highest content of phenolic compounds (109.82 ± 2.36 mg GAE/g). The strongest activity for the DPPH free radical scavenging were recorded by the decoction with IC
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.